EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,014 | -53.7% | 10,004 | 0.0% | 0.02% | -47.6% |
| Q2 2023 | $73,529 | -29.1% | 10,004 | 0.0% | 0.04% | -33.3% |
| Q1 2023 | $103,641 | -12.3% | 10,004 | 0.0% | 0.06% | -25.0% |
| Q4 2022 | $118,147 | -43.7% | 10,004 | 0.0% | 0.08% | -52.0% |
| Q3 2022 | $210,000 | -32.5% | 10,004 | 0.0% | 0.18% | -28.6% |
| Q2 2022 | $311,000 | -24.3% | 10,004 | 0.0% | 0.24% | -9.3% |
| Q1 2022 | $411,000 | -5.5% | 10,004 | 0.0% | 0.27% | -2.2% |
| Q4 2021 | $435,000 | -13.2% | 10,004 | 0.0% | 0.28% | -18.8% |
| Q3 2021 | $501,000 | -20.5% | 10,004 | 0.0% | 0.34% | -15.8% |
| Q2 2021 | $630,000 | -32.2% | 10,004 | 0.0% | 0.40% | -29.0% |
| Q1 2021 | $929,000 | -10.2% | 10,004 | 0.0% | 0.57% | -30.2% |
| Q4 2020 | $1,034,000 | 0.0% | 10,004 | 0.0% | 0.82% | +0.7% |
| Q3 2020 | $1,034,000 | – | 10,004 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |